Xiaoqin Jiang

1.1k total citations
71 papers, 818 citations indexed

About

Xiaoqin Jiang is a scholar working on Radiation, Surgery and Molecular Biology. According to data from OpenAlex, Xiaoqin Jiang has authored 71 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiation, 13 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Xiaoqin Jiang's work include Advanced Radiotherapy Techniques (14 papers), Radiation Therapy and Dosimetry (7 papers) and Medical Imaging Techniques and Applications (6 papers). Xiaoqin Jiang is often cited by papers focused on Advanced Radiotherapy Techniques (14 papers), Radiation Therapy and Dosimetry (7 papers) and Medical Imaging Techniques and Applications (6 papers). Xiaoqin Jiang collaborates with scholars based in China, United States and Taiwan. Xiaoqin Jiang's co-authors include Sen Bai, Youling Gong, Qingfeng Jiang, Renming Zhong, Yingjie Zhang, Guangjun Li, Kui Wu, Yong Xu, Qingfeng Xu and Yali Shen and has published in prestigious journals such as PLoS ONE, Chemical Engineering Journal and International Journal of Molecular Sciences.

In The Last Decade

Xiaoqin Jiang

63 papers receiving 802 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoqin Jiang China 18 400 302 279 123 105 71 818
Andrew D. Vassil United States 15 218 0.5× 314 1.0× 119 0.4× 176 1.4× 616 5.9× 24 1.5k
Hiromitsu Takizawa Japan 19 37 0.1× 537 1.8× 156 0.6× 313 2.5× 255 2.4× 139 1.3k
David A Schauer United States 18 267 0.7× 206 0.7× 503 1.8× 77 0.6× 47 0.4× 52 1.1k
Bo Qiu China 22 123 0.3× 585 1.9× 253 0.9× 182 1.5× 412 3.9× 134 1.7k
Ken Harada Japan 21 56 0.1× 158 0.5× 184 0.7× 109 0.9× 333 3.2× 78 1.2k
Peiman Haddad Iran 14 48 0.1× 247 0.8× 185 0.7× 42 0.3× 206 2.0× 55 623
Koichiro Kenzaki Japan 13 23 0.1× 276 0.9× 77 0.3× 182 1.5× 78 0.7× 42 578
Andrea L. DiCarlo United States 20 48 0.1× 285 0.9× 755 2.7× 231 1.9× 39 0.4× 49 1.1k
Chunli Yang China 15 68 0.2× 137 0.5× 69 0.2× 85 0.7× 56 0.5× 44 664
Carl J. Johnston United States 11 26 0.1× 217 0.7× 261 0.9× 137 1.1× 47 0.4× 22 698

Countries citing papers authored by Xiaoqin Jiang

Since Specialization
Citations

This map shows the geographic impact of Xiaoqin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoqin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoqin Jiang more than expected).

Fields of papers citing papers by Xiaoqin Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoqin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoqin Jiang. The network helps show where Xiaoqin Jiang may publish in the future.

Co-authorship network of co-authors of Xiaoqin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoqin Jiang. A scholar is included among the top collaborators of Xiaoqin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoqin Jiang. Xiaoqin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Yida, et al.. (2025). Mapping the therapeutic landscape of CRISPR-Cas9 for combating age-related diseases. Frontiers in Genome Editing. 7. 1558432–1558432. 1 indexed citations
3.
Liu, Fei, et al.. (2025). Bio-based thermoplastic poly(ether-ester) elastomers from 2,5-thiophenedicarboxylic acid with high stiffness and elasticity. Chemical Engineering Journal. 510. 161856–161856. 2 indexed citations
4.
Jiang, Xiaoqin, et al.. (2024). Isolation and identification of active components from Grifola frondosa and its anti‐EV71 virus effect. Journal of the Science of Food and Agriculture. 104(7). 4453–4464. 2 indexed citations
5.
Jiang, Xiaoqin, et al.. (2024). Cerium/sulfur co-doped spinel iron-cobalt oxide@carbon interconnected mesh networks as superior peroxymonosulfate activator for tetracycline degradation. Journal of environmental chemical engineering. 12(3). 112873–112873. 3 indexed citations
6.
Wu, Xiangwei, Tao Yang, Xiaoqin Jiang, et al.. (2024). New thermoplastic poly(ester–ether) elastomers with enhanced mechanical properties derived from long-chain dicarboxylic acid for medical device applications. Journal of Materials Chemistry B. 13(5). 1731–1743. 3 indexed citations
7.
Jiang, Xiaoqin, et al.. (2023). Probiotics-Fermented Grifola frondosa Total Active Components: Better Antioxidation and Microflora Regulation for Alleviating Alcoholic Liver Damage in Mice. International Journal of Molecular Sciences. 24(2). 1406–1406. 4 indexed citations
8.
Ge, Xiaodong, Xiaoyu He, Xiaoqin Jiang, et al.. (2022). 6,8-(1,3-Diaminoguanidine) luteolin and its Cr complex show hypoglycemic activities and alter intestinal microbiota composition in type 2 diabetes mice. Food & Function. 13(6). 3572–3589. 26 indexed citations
9.
He, Xiaoyu, et al.. (2022). Ameliorating Effect on Glycolipid Metabolism of Spirulina Functional Formulation Combination from Traditional Chinese Medicine. Oxidative Medicine and Cellular Longevity. 2022(1). 3910116–3910116. 9 indexed citations
11.
Jiang, Xiaoqin, Hedong Li, Yi Qu, et al.. (2018). Huwe1 is a novel mediator of protection of neural progenitor L2.3 cells against oxygen‑glucose deprivation injury. Molecular Medicine Reports. 18(5). 4595–4602. 3 indexed citations
12.
Zhou, Huiling, Jingjing Bao, Xiaowei Zhu, et al.. (2018). Retinoblastoma Binding Protein 5 Correlates with the Progression in Hepatocellular Carcinoma. BioMed Research International. 2018. 1–9. 10 indexed citations
13.
Gutbier, Birgitt, Xiaoqin Jiang, Norbert Weißmann, et al.. (2016). The Tie2-Agonist Vasculotide Protects Lungs from Pneumonia-induced Barrier Disruption. Pneumologie. 70(S 01). 1 indexed citations
14.
Ni, Juan, et al.. (2015). Effect of Dexmedetomidine on Preventing Postoperative Agitation in Children: A Meta-Analysis. PLoS ONE. 10(5). e0128450–e0128450. 33 indexed citations
15.
Jiang, Xiaoqin. (2015). Speech Emotion Recognition Using Semi-Definite Programming Multiple-Kernel SVM. Beijing Youdian Xueyuan xuebao. 1 indexed citations
16.
17.
Wang, Chu, Andrew Ferrell, Giao Nguyen, et al.. (2012). SU‐D‐217BCD‐06: Evaluation of Effective Dose during Neuro 3‐D Imaging Using a C‐Arm Cone‐Beam CT System. Medical Physics. 39(6Part3). 3620–3620.
18.
Jiang, Xiaoqin. (2009). Clinical Study Progress of Extract of Ginkgo Biloba Leaf. 1 indexed citations
19.
Jiang, Xiaoqin. (2009). Developing Strategy of Technological Innovation on Jiangsu Time-honored Brand Corporation. Commercial Research.
20.
Jiang, Xiaoqin, Tianfu Wen, Biao Li, et al.. (2008). University of California at San Francisco Criteria Can Be Applied to Living Donor Liver Transplantation for Hepatocellular Carcinoma: Single-Center Preliminary Results in 27 Patients. Transplantation Proceedings. 40(5). 1476–1480. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026